U.S. Health Care Costs and Outcomes Lag Behind Peer Economies
In 2024, the United States spent about 17.6 percent of GDP on health care, far above other OECD nations, yet life expectancy remains below the OECD average according to the latest OECD Health Statistics. Per capita spending exceeded $13,000, driven by high prices for hospital services, prescription drugs, and administrative complexity, with many households facing deductibles above $5,000 and premiums rising faster than wages. The Commonwealth Fund 2024 international survey ranked the U.S. last among 10 high-income countries on access, equity, and care outcomes, while noting that other nations achieve broader coverage at roughly half the cost per person. For investors, the cost burden reduces labor competitiveness and raises uncertainty around future employer-sponsored coverage and public program financing Forbes.
High prices for branded drugs, hospital consolidation, and opaque billing practices continue to push total national health expenditures higher each year, even as millions remain underinsured or skip care due to cost. The Centers for Medicare & Medicaid Services projects that national health spending will grow at an average rate of 5.5 percent annually through 2033, outpacing GDP growth and increasing the federal share of spending on Medicare and Medicaid. Despite these trends, the U.S. still ranks near the bottom among wealthy nations on avoidable mortality and access to timely primary care, according to the Commonwealth Fund Commonwealth Fund.
Insurance Structure, Administrative Waste, and Coverage Gaps
The U.S. relies on a fragmented mix of employer-sponsored insurance, Medicare, Medicaid, and the Affordable Care Act marketplaces, leaving millions in coverage gaps or facing high cost-sharing. In 2024, the Census Bureau reported that about 25 million people remained uninsured, with uninsured rates highest among working-age adults in states that did not expand Medicaid, while employer premium costs for family coverage topped $25,000 annually according to the Kaiser Family Foundation. Administrative costs in the U.S. system are among the highest in the world, with billing, coding, and prior-authorization processes consuming an estimated 15 to 30 percent of total spending, a burden that falls on providers, insurers, and patients alike Health Affairs.
Employers, particularly in sectors such as retail, hospitality, and construction, face rising premium contributions that squeeze margins and complicate workforce planning, while workers see stagnant real wages alongside increasing deductibles and out-of-pocket maximums. Large insurers and hospital systems continue to consolidate, giving them greater negotiating leverage over prices, yet price transparency rules have had limited impact on the sticker prices that patients and small businesses encounter. For companies with self-funded plans, stop-loss carriers and third-party administrators add another layer of cost and complexity, making the U.S. system one of the least efficient among advanced economies Kaiser Family Foundation.
Innovation, Investment, and the Risk of a Two-Tier System
The United States remains a global leader in biomedical research and medical technology, with top hospitals, biotech firms, and venture-backed startups driving advances in genomics, immunotherapy, and digital health tools. However, high list prices for breakthrough therapies, combined with restrictive formularies and prior-authorization barriers, mean that many patients face delays or cannot afford the latest treatments,